Xellia Pharmaceuticals Aps - B0768

Company-provided description, not an official-source fact. Certifications, capacities, years and market positions stated in it are the company's own claims until a record below confirms them.

ANVISA, le régulateur brésilien de la santé, détient un certificat de bonnes pratiques de fabrication valide pour cette plante, couvrant les ingrédients pharmaceutiques actifs, valable jusqu'au 2028-03-18. Le certificat est délivré après une inspection de l'usine elle-même, c'est pourquoi un régulateur étranger nomme ce site : les produits fabriqués ici sont autorisés sur le marché brésilien. Numéro de processus 25351884748202303.

Type
manufacturer (our classification of the record, not a statement by the company)
Role
Manufacturer (official record)
Location
Denmark
Categories
Production pharmaceutique
Markets
Danemark, Brésil

Listed in a source registry

ANVISA (Brazilian Health Regulatory Agency) open data

What is established and what is not

No researcher review has been written for this company yet. 1 official record from 1 official source is on file. 2 other entries are not official records: our own technical checks and searches, open directory listings, our inferences or the company's own statements. Everything is listed below with its evidence type: each entry confirms only what it literally says; none of them is a review. The manufacturing role above rests on the official records listed below, and only as far as each literally goes: a facility registration or licence is not an observation of current production. Nothing here confirms ownership or trading status beyond what each record literally says.

Facts on file, each with its evidence type

Import rules for these goods

Check independently

Before a first order, ask for the legal entity's registration number and country, then check it in the official register.

Full page for humans